Authors: Cales, P Masliah, C Bernard, B Garnier, P Silvain, C Szostak-Talbodec, N Bronowicki, J Ribard, D Botta-Fridlund, D Hillon, P Besseghir, K Lebrec, D

Citation: P. Cales et al., Early administration of vapreotide for variceal bleeding in patients with cirrhosis, N ENG J MED, 344(1), 2001, pp. 23-28

Authors: Cales, P Lacave, N Silvain, C Vinel, JP Besseghir, K Lebrec, D

Citation: P. Cales et al., Prospective study on the application of the Baveno II Consensus Conferencecriteria in patients with cirrhosis and gastrointestinal bleeding, J HEPATOL, 33(5), 2000, pp. 738-741

Authors: Blanco-Prieto, MJ Besseghir, K Zerbe, O Andris, D Orsolini, P Heimgartner, F Merkle, HP Gander, B

Citation: Mj. Blanco-prieto et al., In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres, J CONTR REL, 67(1), 2000, pp. 19-28

Authors: Blanco-Prieto, MJ Besseghir, K Orsolini, P Heimgartner, F Deuschel, C Merkle, HP Ho, NT Gander, B

Citation: Mj. Blanco-prieto et al., Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres, INT J PHARM, 184(2), 1999, pp. 243-250

Authors: Rothen-Weinhold, A Besseghir, K Vuaridel, E Sublet, E Oudry, N Gurny, R

Citation: A. Rothen-weinhold et al., Stability studies of a somatostatin analogue in biodegradable implants, INT J PHARM, 178(2), 1999, pp. 213-221